Melissa Franiak
Nurse Practitioner · Fishers, INNPI 1477918639
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,230 and has fallen 80.7% since, to $237 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$788
- AbbVie$466
- Painteq LLC$396
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$306
- Nevro Corp.$228
- GRT US Holding, Inc.$215
- plus $2K from 26 others
What the payments were for
- Travel & lodging$221%
- Food & beverage$4,06199%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 52 | $788 |
| AbbVie | 31 | $466 |
| Painteq LLC | 22 | $396 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $306 |
| Nevro Corp. | 6 | $228 |
| GRT US Holding, Inc. | 12 | $215 |
| Abbott | 8 | $182 |
| Avanos Medical | 2 | $158 |
| IBSA Pharma Inc. | 9 | $137 |
| Collegium Pharmaceutical, Inc. | 8 | $126 |
| Averitas Pharma Inc. | 6 | $125 |
| Lilly USA, LLC | 6 | $121 |
| Globus Medical | 4 | $120 |
| Boston Scientific | 10 | $108 |
| Redhill Biopharma Inc. | 5 | $95 |
| Almatica Pharma LLC | 3 | $57 |
| Pfizer | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Amgen | 2 | $37 |
| Relievant Medsystems, Inc. | 1 | $34 |
| Vertos Medical, Inc. | 2 | $34 |
| Si-bone, Inc. | 1 | $32 |
| MML US, Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Alfasigma USA, Inc. | 2 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $21 |
| Crossroads Orthopedics, LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERATOR$145
- INTELLIS ADAPTIVESTIM$110
- Senza$110
- PAINTEQ$101
How this compares
$4,083 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 17 | $15,752 |
| SymproicNaldemedine Tosylate | 12 | $5,418 |
| Buprenorphine | 12 | $4,105 |
| Pregabalin | 77 | $2,449 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $2,356 |
| Gabapentin | 107 | $1,825 |
| Buprenorphine Hcl | 21 | $1,797 |
| Duloxetine Hcl | 48 | $1,608 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $798 |
| Tramadol Hcl | 46 | $534 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $352 |
| Meloxicam | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $126 | $15,75217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Fishers
- Ryan PilkeyFishers$12K
- Amanda LuckeFishers$11K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.